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That a central immunological unresponsive state exists to our own body con- 
stituents is widely accepted. The precise role played by the various cell  types 
of the lymphoid system in the maintenance or abrogation of this unresponsive- 
ness  to  self remains unclear.  A  large number  of nonself-antigens  require  the 
collaboration of thymus-derived (T) and bone marrow-derived (B) lymphocytes 
(1,  2). Although both T  and B  cells may be made unresponsive, only one cell 
type  need  be  in  order  that  the  intact  animal  remain  unresponsive  (3).  In  a 
rabbit  model,  the  cellular  events  in  the  termination  of  unresponsiveness  to 
bovine  serum  albumin  (BSA), 1 by  the  injection  of  cross-reacting  albumins, 
were best  explained  by assuming  that  the  T  cells,  but  not  the  B  cells,  were 
unresponsive  to  BSA  and  to  cross-reacting  determinants  on  other  albumins 
(4). Such a  situation may explain the apparent ease with which unresponsive- 
ness  to  self components may be  abrogated  in autoimmune  disorders  such as 
thyroiditis (5-7) and rheumatic fever (8). 
The present investigations were undertaken  to  directly assess by adoptive 
transfer,  antigen-binding  and  antigen-suicide  techniques,  the  interactions  of 
T  and B  cells during the induction of autoantibody to syngeneic thyroglobulin 
(Tg)  and  during  the  production  of  thyroid  lesions. 
Materials and Methods 
Immunization of Mice with Heterologous Tg.--6--8-wk  old female A/J mice (Jackson Labo- 
ratories, Bar Harbor, Maine) were injected intraperitoneally with 0.5 mg of an equal mixture 
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of soluble human, equine, and bovine Tg's daily for 6 days. A second and third series of injec- 
tions were given with a 2-wk interval between series. 
Isolation of Tgs.--Bovine and equine thyroids were obtained from local slaughterhouses, 
and murine thyroids were removed from normal female A/J mice. Human thyroids removed 
from autopsy specimens were kindly provided by Dr. Robert Nakamura, University of Cali- 
fornia at Irvine. The thyroids were minced and extracted in the cold with normal saline. Cell 
and tissue debris were removed by centrifugation in the cold at 10,000g for 30 min. The super- 
natant material was precipitated in the cold with ammonium sulfate as described by Rose and 
Stylos (9). The Tg-rich fraction (1.7 M) was redissolved in phosphate-buffered saline (PBS), pH 
7.2, and chromatographed on a 2.5 X  90 cm Sephadex G-200 column (Pharmacia Fine Chemi- 
cals, Inc., Piseataway, N. J.). The excluded peak was isolated and shown to contain approxi- 
mately 90-95% Tg and some 5-10% serum proteins by immunoelectrophoresis (IEP). Small 
samples of each Tg were further purified by DEAE-cellulose chromatography as described 
previously and were found to be free of serum protein by IEP. The DEAE-purified Tg's were 
used in autoradiographic and antigen-binding capacity assays. 
Detection of Plaque-Forming Cells (PFC)  to Heterologous Tg.--Heterologous  Tg was co- 
valently coupled  to goat erythrocytes essentially as described previously  (10).  The plaque 
assay was a modification (ll) of the method of Jerne to assay for direct PFC (D-PFC)  (12). 
For detection of indirect PFC  (I-PFC), a  goat antimouse IgG antiserum was appropriately 
diluted in a  complement source of guinea pig serum. Appropriate controls were included in 
each plaque assay to determine the background to the target erythrocyte. 
Histology.--Thyroids  were removed from exsanguinated mice and placed in Bouin's solu- 
tion for 8-24 h. The hematoxylin-eosin and periodic acidic-Sehiff sections were examined and 
graded for increased cellularity. Sections were scored from 0  to 4+.  A  normal thyroid was 
given a 0 score. A score of 1+ was given when there was interstitial accumulation of inflamma- 
tory cells distributed between two or more follicles. Where there were one to two loci of in- 
flammatory cells equivalent in size to a folficle, a rating of 2-[- was given. A 3+ score indicated 
that about 10-40% of the thyroid was replaced by inflammatory cells and a score of 4+ indi- 
cated that greater than 40% was replaced by inflammatory cells. 
lodination  of Tg.--DEAE chromatographically purified Tg's were iodinated as described 
by McConahey and Dixon  (13);  for the autoradiographic and antigen-suicide studies,  the 
specific activities ranged from 33-85 and 280-330 ~Ci//zg protein, respectively. For quantita- 
tive determinations of serum antibody to Tg by the antigen-binding capacity assay, the Tg's 
were labeled to a specific activity of approximately 0.1-0.5/zCi/~g protein. 
Nitrogen Determinations.--Protein  nitrogen determinations were performed by a modifica- 
tion of the micro-Kjeldahl technique using the Techuicon autoanalyzer (Teehnicon Instru- 
ment Corp., Tarrytown, N. Y.) (14). 
Autoradiographic Assay  of Antigen-Binding  Lymphocytes  (ABL).--The  autoradiographic 
method was similar to that described by Davie and Paul (15).  Briefly, thymuses and spleens 
were removed from the mice after exsanguination and single-cell suspensions from each organ 
were made in minimal essential medium  (MEM)  or RPMI-1640  (Grand Island Biological 
Co., Grand Island, N. Y.) supplemented with 10% fetal ealf serum (FCS) and 0.1% sodium 
azide. To 200/zl of medium containing 20 X  l0 s nucleated cells was added 100 or 500 ng of 
[12SI]Tg; the cell suspensions were held at 4°C for 30 min. To remove unbound [12~I]Tg from 
the cell suspensions, each eell preparation was layered over 7 ml of FCS and eentrifuged at 
200g. This step was repeated three times. 
Cell smears were made on precleaned slides,  air-dried, fixed, and emulsed in NTB-2  (East- 
man Kodak Co., Rochester, N. Y.). Exposure times varied from 14-21 days; however, in one 
instance the exposure time was 90 days. The slides were developed and stained with Giemsa, 
and in each preparation, 10-200 >( 103 cells were scanned for the presence of grains. A positive 
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there could be no discernible damage to the membrane or to other structures; (c) the cell could 
not touch other ceils or cellular debris; (d) the cell had to have at least a 20-fold increase above 
background (~-d grain/cell) grains on its surface or distributed about its circumference. 
In blocking experiments with unlabeled Tg, the cell suspensions were mixed with a  750- 
15,000-fold  excess of unlabeled Tg diluted in MEM and the mixture incubated at 4°C for 2 h. 
Then, the cell suspensions were washed twice with fresh MEM before incubation with [125I]- 
Tg under standard conditions.  In blocking experiments with antisera, the cell suspensions 
(200/Zl) were incubated with equal volumes of appropriately diluted antisera for 2 h  at 4°C 
and washed twice in fresh MEM before the addition of [12~I]Tg. 
Antisera.--Before  use, all antisera were heated at 56°C for 30 min and absorbed with A/J 
thymocytes (108 cells/ml of antiserum) in order to remove heterophile antibodies to murine 
cells. Normal goat and rabbit sera were obtained from animals before immunization in order to 
assess the background inhibitory capacity of each serum. The antimouse Fab antiserum was 
prepared by repeated injections of a  goat with Fab fragments from papain-digested normal 
mouse IgG. This antisera detected K, X, and Fd determinants as ascertained by Ouchterlony 
analysis. A rabbit antimouse/z-chain serum was prepared by repeatedly injecting rabbits with 
purified MOPC-104 E  IgM myeloma protein. To render the antisera/z-chain specific,  it was 
absorbed with neonatal mouse serum, MOPC-46  K-chains,  h-chains of 104 E, and Fab frag- 
ments of PC-5 myeloma. The anti-IgG heavy-chain specific antiserum was prepared in rabbits 
by repeated injections of mouse IgG in Freund's complete adjuvant and was absorbed for 
"),-chain  specificity with Fab fragments of  PC-5  myeloma,  MOPC-46  K-chain,  MOPC-315 
IgA myeloma, and MOPC-104 E  IgM myeloma proteins. All the antiheavy-chain antisera 
and the anti-Fab antiserum were tested by indirect immunofluorescence and direct immuno- 
fluorescence,  respectively,  on  ethanol-fixed mouse myeloma cells  ($121,  W33,  MOPC  315, 
MOPC  104E, PC-5, and 183). These studies permitted  both the determination of the spec- 
ificity and the relative potency of each antiserum. By this test, all the antisera were judged 
to be specific and to give positive fluorescence at a dilution of greater than 1:40. 
Quantitation of Antibody to Mouse Tg.--The technique employed is a  modification of the 
antigen-binding capacity test (ABC) as described by Farr (16).  To 20/zl of  [lalI]murine Tg 
(3.85/zg N/ml) at 0.1/ZCi//Zg protein was added 20/Zl of antibody serially diluted in 1:2 nor- 
mal mouse serum and  1 /zg of [125I]PC5 myeloma protein (~/2aK) or of [125I]mouse  IgG  in 
each tube as an internal control in order to determine the amount of mouse Ig precipitated 
by the coprecipitating antiserum. The tubes were mixed and incubated at 37°C for 1  h  and 
overnight at  4°C;  then, an appropriate  quantity  of  goat antimouse Fab  (IgG)  antiserum 
was added to each tube in order to precipitate the mouse immunoglobulins (Ig). The mixture 
was incubated at 37°C for 60 min and then at 0°C for 00 min, at which time a  heavy pre- 
cipitate formed. The precipitate was pelleted by centrifugation (in the cold) at 1000g for 20 
min and the supernate removed. The pellet was resuspended in 2 ml of cold PBS, pH 7.2, and 
the centrifugation process repeated.  The final supernate was  removed and  the precipitate 
counted in a  two channel, well-type gamma counter. For each dilution of antisera, the per- 
centages of Tg and of mouse Ig precipitated were calculated. A plot of the log dilution of the 
antiserum versus the percent Tg remaining in the supernate produced a  sigrncid curve. The 
dilution at which 33% of the Tg was bound was determined from the semilogarithmic graph. 
This number allowed the calculation of the ABC value for each antiserum. Normal mouse 
serum served as a  background control for each experiment in which less than 2% of the Tg 
added was bound. Between 85-100% of the mouse Ig in each antiserum dilution was precipi- 
tated by 200 #1 of goat antimouse Fab antiserum. To determine the degree to which heterol- 
ogous Tg would competitively inhibit the binding of [lalI]mousc Tg by selected antisera,  the 
ABC assay was modified slightly. 5 #l-aliquots of concentrated (40 mg protein/ml) individual 
heterologous Tg's were added to serial dilutions of antisera and the mixture incubated for 1 h 
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followed as described above. As a control for dilution effect, 5/~1 of FCS was added in place of 
heterologous Tg. Additionally, pooled immune mouse antisera were absorbed at equivalence 
with an equal mixture of soluble equine, human, and bovine Tg, until no further precipitation 
was observed, at which time 4 mg or 40 mg of an equal mixture of bovine and equine Tg were 
added  to insure completeness of absorption.  As in the above experiment, an aliquot of the 
antisera had a volume of either PBS or FCS added, which was equivalent to that of the added 
Tg. All the antisera were tested for the capacity to bind either iodinated mouse or iodinated 
bovine Tg, as described previously. 
t~ Antigenic Suicide of Normal Bone Marrow and Thymus.--Syngeneic  mouse Tg was iodi- 
nated with 125I at a specific activity of 280-330  #Ci//zg protein as described previously (13). 
Normal thymocytes and bone marrow were collected from 6-8-wk old A/J female mice. The 
cells were suspended in MEM with 10% FCS at 5 ×  10 ~ cells/ml and were incubated  sepa- 
rately with [l~SI]murine Tg at a ratio of approximately 3 #g/10 s ceils. The cell suspensions 
were held at 4°C for 5 h. Then, the cells (5 ml) were layered over 20 ml FCS and centrifuged at 
200g for 15 rain in the cold and the process was repeated twice. Mter the final wash, the treated 
cells together with untreated lymphocytes from the other cooperating cell line were suspended 
in MEM and injected intravenously into lethally (900 R) irradiated, thymectomized (Tx) re- 
cipients. 4--6 days after reconstitution, the animals were immunized according to the standard 
regimen of heterologous Tg's. In one experiment, additional mice in each group were sacrificed 
at a later time (day 52) to determine the incidence and extent of thyroid lesions. 
RESULTS 
Detection  of PFC to  Thyroglobulin.--As  shown  in  Table  I,  a  PFC  response 
to  bovine,  equine,  and  human  Tg's  was  observed  in  the  spleens  of  mice  in- 
jected with an equal mixture of human,  bovine, and equine Tg. The responses 
to  bovine and  equine Tg were similar,  whereas  the response  to  human  Tg was 
lower than  that  observed with  either  bovine or equine.  This  was  a  consistent 
finding during these studies,  and for this reason, in all subsequent  PFC  assays, 
bovine Tg was  selected  as  the  antigen  of choice for  the  PFC  assay.  Although 
not shown in Table I, D-PFC  were observed only during the first 5  days after 
the cessation of the first series of daily Tg injections. The D-PFC  response was 
usually  500-3,000  PFC/spleen.  However,  after  the  second  and  third  series  of 
Tg injections,  the plaque  response  was  almost  exclusively of  the  I-PFC  type. 
Appearance  of  Serum  Antibody  and  Lesions.--Because  of  the  excessive 
TABLE I 
Detection of Plaque-Forming Cells in A/J Mice Immunized with a Mixture of Human,  Equine, 
and Bovine Thyroglobullns 
Thyroglobulin tested 
Indirect plaque-forming  cells per: 
106 Spleen  Cells*  Spleen 
Bovine  125  -4-  11~  39864  -4-  8842 
Equine  82  -4-  13  27222  4-  8040 
Human  39  4-  13  13460  4-  5110 
* Four mice were used in this assay and plaqued 1 day after the last Tg injection. 
:~ Arithmetic mean 4-  I standard error of mean. JAMES A.  CLAGETT AND WILLIAM O.  WEIGLE  647 
amount of Tg required during the conjugation of antigen to erythrocytes and 
in  consideration  of  the  limited  amount  of murine  Tg  available, no  attempt 
could be made to directly assay for PFC to murine Tg. Rather, a modification 
of the ABC was employed to measure antibody reacting with murine Tg. The 
data in Fig. 1 show that only after the second and third series of Tg injections 
do appreciable amounts of antibody reacting with syngeneic Tg appear in the 
serum. The dramatic drop (88 %) in the serum antibody levels at days 40-45, 
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FIG. 1. The serum antibody response (O) to murine thyroglobulin measured by a modified 
antigen-binding capacity assay  (expressed as micrograms antibcdy  nitrogen per milliliter 
serum). Each point represents the mean of 6-15 mice, 4-1 SE (vertical lines). The I-PFC re- 
sponse to bovine thyroglobulin by the spleen is included (D). The arrows indicate the number 
of soluble thyroglobulin injections on the indicated days. 
the ABC. The in vivo absorption of serum antibody suggests that most of the 
antibody produced  which  reacts  with  murine  Tg,  also  cross-reacts with  the 
hetero'.ogous Tg's.  Furthermore,  the  appearance  of  PFC  to  bovine  Tg  pre- 
cedes by 3-5 days the subsequent elevation of antibody in the sera to murine 
Tg. As antibody reappears in the circulation (day 48) and reaches a maximum 
(day  50)  value,  the  incidence  of  thyroid  lesions  is  low;  however,  thereafter 
(days 51-55) the incidence of lesions reaches a maximum of approximately 90 % 
and the antibody to murine Tg declines. 
ttistology.--A  representative lesion  at day 52  is shown in  Fig.  2 where  the JAMES  A.  CLAGETT AND  WILLIAM  O.  WEIGLE  649 
noteworthy histopathological features of the inflammatory loci are the preva- 
lence of neutrophiles, dissolution of colloid material, and disruption of follic- 
ular integrity. A  minor mononuclear inflammatory cell reaction was also ob- 
served. The mononuclear inflammatory reaction became the prominent histo- 
logical feature from day 54 through 75. 
Specificity of Serum Antibody.--As previously indicated, the serum of mice 
immunized with a  mixture of heterologous Tg's appeared to contain, in large 
part, antibodies cross-reacting to common determinants shared by all three of 
the heterologous Tg's. The administration of cross-reactive heterologous Tg's 
allows collaboration of T  and B  cells  because the noncross-reactive determi- 
nants on the heterologous Tg's stimulate a  specific population of T  cells.  At 
the same time,  antigen-reactive B  cells  react with both cross-reactive deter- 
minants  and  heterologous-specific  determinants  and  as  such,  both  cross- 
reactive antibody and heterotogous-specific antibody are produced. Thus, the 
specificity of antibody appearing in the serum reflects the cellular status of the 
host. In this respect, these experiments were designed to investigate the degree 
of cross-reactivity of antibody and whether any antimurine Tg-specific anti- 
body was produced.  The data in Table II demonstrate that bovine, equine, 
and  human  Tg,  added  individually  at  saturating  levels,  produced  almost 
identical inhibition (73-76 %) of the ABC to mouse Tg. As the level of soluble 
inhibitor decreased,  the  degree of  inhibition declined correspondingly. As  a 
control for dilution and specificity, an excess of non-Tg proteins and FCS was 
added to an aliquot of pooled immune serum. The FCS produced no detectable 
inhibition  of  the  ABC  value.  An  additional  aliquot  of  the  antiserum  was 
absorbed at equivalence with an equal mixture of equine, bovine and human 
Tg's, and an excess unlabeled Tg (4 mg or 40 mg) added to insure complete- 
ness of absorption. This absorbed antiserum contained no antibodies capable 
of binding iodinated bovine Tg, but retained a small but significant population 
of antibodies specific for murine Tg when a mixture of 4 mg of the excess un- 
labeled Tg's were added. At 40 mg excess of bovine and equine Tg, no anti- 
body to murine Tg remained. An aliquot of appropriately diluted unabsorbed 
antiserum  served  as  a  control  to  which  the  absorbed  antiserum  was  com- 
pared. These data show that all the antibody produced that reacts with murlne 
Tg also cross-reacts with the heterologous antigens. 
Thymus  and  Bone-Marrow Synergism  in  Production of  Antibody and  of 
Thyroid Lesions.--As  shown  in  Table  III,  lethally irradiated  and  Tx  mice 
reconstituted with normal bone marrow, and injected with heterologous Tg's 
did not produce  antibody (PFC)  and did not have discernible lesions.  Con- 
versely, lethally irradiated Tx mice reconstituted with normal bone marrow 
or "B" spleen cells and normal thymocytes were able to generate both  I-PFC 
FIG. 2. Sections of thyroid removed at day 52. Hematoxylin and eosin.  3-[- reaction. Fig. 
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TABLE II 
Specificity of Serum Antibody in ABC Assay 
Inhibi- 




















200 X of unlabeled human Tg 
80 X of unlabeled human Tg 
40 X of unlabeled human Tg 
4 X of unlabeled human Tg 
200 X of unlabeled bovine Tg 
200 X of unlabeled equine Tg 
200 X of FCS 
200 X  of FCS 
Pooled immune absorbed with mixture  4 mg* 
of unlabeled heterologous Tg's  40 mg* 
Pooled immune absorbed with mixture  4 mg* 














* Equal mixture of bovine and equine Tg added to insure completeness of absorption  of 
the pooled immune antisera. 
and  thyroid  lesions,  after  heterologous  Tg  injections.  Similarly,  recipients 
of  normal  spleen  cells  produced  PFC  and  lesions.  By the  nature  of the  ex- 
perimental  protocol,  the  possibility  that  recipients  reconstituted  with  only 
thymocytes  could  produce  lesions was untestable,  since such mice died from 
hematopoietic  stem  cell  failure  7-10  days  postirradiation.  Thus,  these  T-cell 
reconstituted mice do not survive the 50-60 days normally required for lesion 
production. 
Effect  of Prior Exposure of B Cells to Tg as Measured by Synergistic  Response 
with T  Cells.--The  experiment  described in Table  IV was designed  to answer 
the following two questions: (a) can B cells be stimulated by repeated exposure 
to antigen, in the absence of T  cells, to produce antibody; and (b)  what are  the 
effects of repeated  Tg injections  on  the  synergistic  capacity of such B  cells? 
Two groups of animals  were Tx,  irradiated,  and  reconstituted  with 40 X  l0 s 
normal  bone marrow/recipient.  One group received the standard heterologous 
Tg  injection  regimen,  and  the  other  received  saline.  2  wk  after  the  last  Tg 
injection,  the  mice were  sacrificed  and  the  B  spleen  cells  of  the  donors plus JAMES  A.  CLAGETT AND  WILLIAM  O.  WEIGLE  651 
TABLE  III 
Thymus  and  Bone-Marrow Cell Collaboration in  Antibody  Plaque-Forming Response and 
Production of Lesions in Experimental A utoimmune Thyroiditis 
No. of  Tx, lethally irradiated* recipient  PFC per:  Le-  an-  imals  mice reconstituted  with:  10  6  Spleen cells  Spleen  sions 
8  40  X  l0 s normal bone-marrow cells~  134  ±  33** 
and 100 X  10 6 normal thymocytes 
11  60 X  106 "B"  spleen cells§  and 100 X  78  ±  13 
10 6 normal thymocytes 
6  40 X  106 normal spleen cells  70  ±  27 
11  40  X  106 normal bone-marrow cells~  0 
34,769  ±  6,668  +I1 
26,799  ±  4,992  +ll 
9,992  ±  3,504  +l[ 
0  --¶ 
* 850 R, whole body irradiation. 
:~ Normal bone marrow was treated with AKR anti-C  3H0 serum plus C. 
§ "B" spleen cells were derived from spleens of animals, thymectomized,  irradiated (850 R), 
reconstituted 6 wk before with normal bone marrow treated with AKR anti-C3HO serum plus 
C. 
[1 The incidence of lesions ranged from 30 to 90~o of the animals in each group. 
¶  None of the animals reconstituted with normal bone marrow showed any evidence of 
lesions at anytime during the course of experimentation. 
** Arithmetic mean -4-1 SE of the mean. 
TABLE  IV 
Effect of Prior Exposure of B Cells to Antigen as Measured by Synergistic Response with T Cells 
No. of  Tx, lethally irradiated* recipient 
an-  mice reconstituted  with:  imals 
Indirect PFC to: 
Bovine Tg per spleen  HoRBC per spleen 
5  30 X  106 "B" spleen cells~ and  49,446  ±  10,881[[, ¶  113,116  -4-  36,960¶ 
90 )<  10 6 normal thymocytes 
5  30  X  106 "B" spleen cells~:  0  0 
5  30 X  106 "B" spleen cells§ and  25,299  ±  13,621¶  54,283  ±  16,137¶ 
90 X  106 normal thymocytes 
5  30 X  l0 s "B" spleen cells§  0  0 
* 850 R, whole body irradiation. 
"B" spleen cells derived from donors previously Tx, lethally irradiated (850 R), recon- 
stituted with 40 X  10 s bone marrow cells treated with AKR anti-Call0 serum plus C t, and 
challenged with the standard regimen of Tg before transfer. 
§ "B" spleen ceils derived from donors previously Tx, lethally irradiated (850 R), reconsti- 
tuted with 40 X  10 6 normal bone-marrow cells treated with AKR anti-Call0 serum plus C  ~. 
[1 Arithmetic mean -4- 1 SE of the mean. 
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normal thymocytes were transferred to intermediate groups of Tx, irradiated 
recipients. All groups were challenged with heterologous Tg and, in addition, 
were immunized appropriately with horse red blood cells (HoRBC) to produce 
maximal PFC response simultaneously with that of the Tg PFC. The spleens 
of  animals  reconstituted  only with  B  cells,  whether  previously exposed  to 
heterologous Tg in the donor or not, did not contain I-PFC to bovine Tg or to 
the  unrelated  antigen, HoRBC.  Conversely,  the  two  groups  of mice  recon- 
stituted with B spleen cells plus thymocytes produced I-PFC to both bovine Tg 
and HoRBC. However, statistical analysis showed that the' responses  of both 
groups to bovine Tg or to HoRBC were not significantly different. This sug- 
gests that prior exposure of B cells to antigens (Tg's) in the absence of T  cells, 
does not influence their capacity to synergize with T  cells in a second host. 
Autoradiographic Detection of [125I]Tg-Binding Lymphocytes.--The  frequency 
of cells from nonprimed mice that bind [125I]syngeneic  Tg is shown in Table V. 
In a  thymocyte preparation incubated with the  [l~SI]murine Tg and exposed 
for 6 wk, the frequency of positive cells was less than 1/105 cells. On the con- 
trary, an aliquot of the same thymocyte suspension incubated with an equal 
mixture of [l~SI]heterologous Tg's  contained 30  positive  cells/105  cells,  when 
exposed for 6  wk.  Higher concentrations of iodinated antigen  (500 ng)  and 
longer exposure times (6 wk) were employed in order to increase the probability 
of finding cells that bind syngeneic Tg. The number of ABL in the spleen of 
normal nonprimed A/J mice that bind [l~SI]mouse Tg was 68/105 lymphocytes 
counted, while the frequency of such cells to bovine or human Tg was 38 and 
130/10 ~ lymphocytes, respectively. 
Inhibition  of [mI]Tg-Binding Lymphocytes.--To  study the nature of the Ig 
receptors on lymphoid cells that bind [~25I]syngeneic  Tg, spleen cells from non- 
primed mice were pretreated with various antisera as shown in Table VI. In- 
cubation of spleen cells with normal goat or rabbit sera did not diminish the 
TABLE  V 
Frequency of Antigen-Bindlng Lymphocytes to Tg in Spleen and Thymus of Normal A /J Mice 
Amount  Source of normal  Antigen-binding 
of [l~I]Tg  lymphoid cells  Iodinated Tg  lymphocytes  per 10~ 
ceils 
ng 
500  Thymus  Mouse  < 1 
500  Thymus  Heterologous mixture  30 
100  Spleen  Mouse  68 
100  Spleen  Human  130 
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TABLE VI 
Inhibition of Antigen-Binding Lymphocytes in Spleens of Normal A/J Mice ~  Antiglobnlin 
Sera and Unlabeled Antigen 
Amount  Antigen-binding  Inhibition  of  [mi]murine  Inhibitor*  lymphocytes per l0  s  of [tUllmurine Tg 
Tg  cells  binding 
ng 
100  MEM  67  0 
I00  1  : 10 normal rabbit serum  66  0 
100  1  : 10 normal goat serum  80  0 
100  1:10 goat anti-Fab (IgG)  5  94 
100  1:10 rabbit anti-g-chain  9  86 
100  1  : 10 rabbit anti-'y-chain  70  0 
100  750 X unlabeled murine Tg  50  25 
100  15,000  X unlabeled murine Tg  13  80 
* Spleen  cells  were pretreated with the various inhibitors, washed twice with fresh medium, 
and exposed to the [126I]murine  Tg. 
capacity of lymphocytes to bind [mI]syngeneic Tg. However, pretreatment of 
cells with goat anfi-Fab (IgG) or rabbit anti-# anfisera inhibited the binding 
by 93 and 87 %, respectively. The rabbit anfi-lgG heavy-chain antisera did not 
inhibit  the appearance of ABL  to  [r~SI]murine Tg.  Unlabeled murine  Tg in- 
hibited the binding of iodinated murine Tg by 25 and 80 % when spleen cells 
were pretreated with a 750- and 15,000-fold excess of unlabeled routine Tg and 
subsequently washed. 
Frequency  of  ABL  in  Spleens  of  Primed  A/J  and  Normal  Nude  Mice.- 
If [mI]syngeneic Tg binds only to B  lymphocytes, then it would follow that 
normal nude (nu/nu) spleens should contain [mI]murine Tg-binding B  lympho- 
cytes with  a  frequency comparable  to  that  of  normal  A/J  mice.  Secondly, 
prolonged immunization with a  heterologous Tg should produce an  increased 
pool of ABL to the injected Tg and to a lesser extent for other cross-reacting 
Tg's. To test these hypotheses, the frequencies of ABL in the spleens of homo- 
zygous athymic nude  and  primed  A/J  mice were  examined  as  indicated  in 
Table  VII.  In  the  nude  mouse,  the  frequency of ABL  for  [mI]murine  and 
[nSI]human Tg was 128 and 140/105 cells counted. Mice previously immunized 
only with human Tg by a standard regimen of injections were used to investi- 
gate the frequency of ABL to human, murine, and bovine Tg. A fourfold en_ 
hanced binding over normal  (Table V) was observed with the three test anti. 654  ROLES O~"  T  AND  B  CELLS IN MURINE THYROIDITIS 
TABLE VII 
Frequency of A ntigen-Binding Lymphovytes in Spleens of Primed A/J and Nude Mice 
Antigen-  Inhibition  [i~5I]Test  binding  of [~I] Tg  antigen  Source of spleen cell  Inhibitor  lymphocytes  binding 









Normal nude  None  128  -- 
Normal nude  None  140  -- 
A/J mice immunized*  8  None  470  -- 
mo before sacrifice 
A/J mice immunized*  8  None  220  -- 
mo before sacrifice 
A/J mice immunized*  8  None  130  -- 
mo before sacrifice 
A/J mice immunized*  8  1 : 10 normal goat  410  13 
mo before sacrifice  serum 
A/J mice immunized* 8  1 : 10 goat anti-Fab  143  65 
mo before sacrifice  (IgG) 
* Injected only with human Tg by standard immunization regimen. 
gens.  The  binding of [~25I]human  Tg in the primed spleen was inhibitable, in 
large part, by antimouse Fab sera, but not by normal sera. 
Antigen  Suicide  of Normal  Bone  Marrow  Cells  by  [125I]Syngeneic Tg.--As 
previously indicated, it is believed that the ABL observed with [u6I]syngeneic 
Tg represent, in part,  immunocompetent  B  cells. Therefore,  such cells should 
be  rendered  immunoincompetent  or  suicided by heavily iodinated syngeneic 
Tg. Since normal thymocytes did not bind [~SI]syngeneic Tg to any significant 
degree,  the  specific function  of  this  cell-type should  not  be  affected  by  the 
incubation in [~I]syngeneic Tg. The data in Table VIII clearly show that nor- 
mal bone-marrow cells were susceptible to the lethal effects of heavily iodinated 
syngeneic Tg.  In two experiments the degree of suppression of the I-PFC re- 
sponse to bovine Tg was 80 %  and 88 %. Of great importance was the observa- 
tion that 56 %  of such animals had no thyroid lesions at a  time (day 52) when 
100 %  of the animals reconstituted with normal thymocytes and bone marrow 
had lesions. Not only was the incidence diminished in the bone-marrow suici- 
dal group, but the severity of the lesions was less than in the control group in 
which  85 %  of  the  animals  had  moderate  inflammatory  involvement  (grade 
1-2+)  as  compared  to  37%  in  the  bone-marrow  suicidal group.  Equally  as 
important was  the finding in both experiments that normal  thymocytes were JAMES  A.  CLAGETT AND  WILLIAM O.  WEIGLE  655 
TABLE VIH 
Antigen Suicide of Normal Bone-Marrow Cell by ~25]-Syngeneic Tg 
Exp, 
no.  T  cells 
100 X  106 normal 
thymocytes 
100 X  106 normal 
thymocytes 
100 X  10 ° thymo- 
cytes and [12sI]- 
mouse Tg 
100 X  106 normal 
thymocytes 
100 X  106 normal 
thymocytes 
100 X  106 thymo- 
cytes and [125I]- 
mouse Tg 
B cells 
25 X  106 bone mar- 
row and [ls~I]- 
mouse Tg 
25 X  10  6 normal 
bone marrow 
25 X  106 normal 
bone marrow 
25 X  106 bone mar- 
row and [126I]- 
mouse Tg 
25 X  106 normal 
bone marrow 









per s~leen to 
bovine Tg 
10,460 4- 2,691,~ 
81,903 -4- 15,446 
50,187 4- 19,387 
3,385 4- 534 
28,037 4- 3,940 
20,693 4- 2,422 
InCidence of thyroid 
lesions:  Grade 




* PFC assay done on day 45. 
:~ Mean 4-SE  of mean. 
§ N'D, not done. 
I] Denominator equals total number of animals examined and numerator equals number of  animals exhibit- 
ing various degrees of inflammation at time of maximal lesions  (day 52). 
not severely affected by heavily iodinated syngeneic Tg, since their responses to 
heterologous Tg were similar in magnitude to control values. The incidence of 
lesions in this group was 90 %; of those animals having lesions, 75 % had moder- 
ate inflammatory involvement. 
DISCUSSION 
The  data presented in  this paper have demonstrated  the  cellular require- 
ments  for  murine  autoimmune  thyroiditis  induced  by  immunization  with 
heterologous Tg's. The production of autoantibody to murine Tg and the in- 
duction of lesions required the presence of both specific T  and B cells. Animals 
that  were  Tx,  irradiated,  reconstituted  with  normal  bone  marrow,  and  in- 
jected with a mixture of soluble heterologous Tg's did not produce any D-PFC 
or I-PFC to heterologous Tg. These same animals showed no histological evi- 
dence of thyroiditis. By contrast, mice that were Tx, irradiated, reconstituted 
with normal thyrnocytes and bone marrow or spleen cells were able to produce 
both D-PFC and I-PFC and thyroid lesions. 
Secondly, the  absence of significant numbers of [a25I]syngeneic Tg ABL in 
the thymus of normal mice would be compatible with the hypothesis that un- 656  ROLES  O1?  T  AND  B  CELLS  IN  M-URINE  THYROIDITIS 
responsiveness  to some self-antigens  resides exclusively in the thymus. How- 
ever,  the  hypothesis also  assumes  that  the B-cell compartment is  immuno- 
competent and as such may recognize cross-reacting  and self-antigens  ([1251] 
syngeneic Tg). Further, the T-cell pool must be capable  of recognizing cross- 
reacting Tg's via noncross-reacting  determinants. The ABL data fully support 
this  hypothesis.  No  significant  number  of  thymic ABL  reacting with  [mI] 
syngeneic  Tg  were  demonstrable while  under similar  conditions,  significant 
numbers (30/105 lymphocytes) of ABL were demonstrable for the cross-reacting 
heterologous Tg's. Normal A/J spleen cell preparations contained comparable 
quantities of ABL for syngeneic and the two heterologous Tg's tested (human 
and bovine).  As expected,  an excess of cold syngeneic or heterologous Tg in- 
hibited the binding of [mI]syngeneic Tg.  In general,  the inhibition data are 
in agreement with those reported by Byrt and Ada (17) who found that pre- 
treatment of normal spleen cells with a 10,000-fold excess of noniodinated flag- 
ellin  reduced  substantially the  numbers  of flagellin ABL. 
In the homozygous athymic nude mouse, comparable numbers of ABL were 
observed with [~SI]human Tg and with [l~SI]murine Tg. The cells binding the 
iodinated antigens in the spleens of these  athymic mice are primarily, if not 
exclusively, B-derived cells (18). This type of experimental  approach does not 
constitute formal proof that the ABL's found with [~SI]syngeneic Tg in  an 
intact normal mouse are exclusively B lymphocytes although by inference it 
must be considered strong supportive evidence for it. Further evidence impli- 
cating B cells as the ABL for self-antigens may be found in a recent report of 
Bankhurst et al.  (19). They demonstrated that peripheral  blood lymphocytes 
from normal human patients subjected to double-layer  antihuman Ig-coated 
bead column which removes lymphocytes bearing large amounts of surface Ig, 
effectively  abolished  or  drastically reduced  the number  of autoradiographic 
positive cells to [~2~I]homologous  Tg. 
Along  these  same  lines,  there was  an increase  in the number of ABL for 
both  syngeneic Tg and heterologous  Tg's when  mice  were  immunized with 
only human Tg 8 mo before sacrifice. The lymphocytes binding [t2~I]syngeneic 
Tg were most probably a  pure  B  population; however,  the source  of those 
cells binding the [~I]heterologous Tg may well have been mixture of B and T 
cells. Ample  evidence  exists  for the presence  of T  cells functioning as ABL 
(20-22).  Whether the ABL which reacted with [125I]syngeneic Tg are B mem- 
ory cells or precursors  of PFC  and whether the immunoglobulin  surface  re- 
ceptors  on these cells are lz- or ~'-chains remains  to be investigated. 
Thirdly, radioactively labeled  syngeneic Tg incubated with normal  bone- 
marrow cells under conditions favoring radiation damage abrogated the capac- 
ity of  these  cells to  collaborate  with  normal  thymocytes when  adoptively 
transferred to a Tx-irradiated host. Upon  challenge with cross-reacting  Tg's, 
such animals  exhibited  a markedly decreased antibody response  (I-PFC) and 
subsequently  had  a  decreased  incidence  of  thyroid  lesions. When  normal JAMES  A.  CLAGETT  AND  WILLIAM  O.  WEIGLE  657 
thymocytes were incubated with [!25I]syngeneic  Tg and injected with normal 
bone-marrow cells into a Tx-irradiated host, a response comparable  to that of 
the control  group was observed  upon challenge with the cross-reacting  Tg's. 
This experiment  established  directly the fact that the B-cell pool  in normal 
mice recognizes the self-antigens and therefore is immunocompetent while the 
T-cell pool does not recognize self-antigens  and therefore  may be considered 
unresponsive. 
The problem  of  antigen suicide of normal  bone  marrow versus  suicide  of 
normal B-derived  lymphocytes is still  a matter of controversy.  Unanue (23) 
was able to demonstrate antigen suicide of normal bone marrow with heavily 
iodinated KLH; on the other hand, Basten et al.  (24) were unable to suicide 
bone-marrow cells but did suicide B-derived cells. Yet it is clear from the work 
of Chiller et al. (3) that bone marrow does contain antigen-sensitive  cells since 
they are  capable  of being rendered unresponsive  with deaggregated human 
gamma globulin. This type of data suggests that normal bone  marrow does 
contain antigen-specific immunocompetent cells. One reason why Unanue (23) 
and we were able  to suicide normal bone marrow may be that substantially 
larger amounts and more intensely iodinated antigen were  employed. 
The  interrelationship between  thyroid lesions and antibody was dramatic- 
ally clarified  with  the  suicide  of normal  bone  marrow.  When  antibody  is 
decreased dramatically, the incidence and severity of lesions decreased. Further 
support for the role of antibody may be ascertained  from the temporal  rela- 
tionship between  the elevation (day 48-50)  of serum antibody reacting with 
mouse Tg and the subsequent appearance  of inflammatory cells in the thyroid 
on day 52.  The histopathological  nature of these  lesions was in part neutro- 
philic  in character;  this type of lesion has often been  associated  with acute 
inflammatory reactions  mediated by antigen,  antibody, and the complement 
system (25, 26). Clinton and Weigle  (10) reported  that rabbits  immunized 
with soluble bovine  Tg exhibited  a  similar  kinetic interrelationship between 
the  appearance  of  splenic  PFC  and serum  antibody to Tg.  In their rabbit 
model,  they found that coincidental  with the appearance  of thyroid lesions, 
I-PFC to rabbit Tg reached a peak in the thyroid. As they suggested, the thy- 
roid may act as  a  specific immunoabsorbent for circulating B  memory cells 
and as such, an accumulation of sensitized lymphocytes specific for rabbit Tg 
would be expected  in the thyroid at this time.  That specific antibody to Tg 
passively transfers thyroiditis has been  dearly demonstrated for rabbits (27) 
and mice (28). On the other hand,  the  degree  of  thyroiditis in  guinea pigs 
has been correlated  best with the level of cellular immunity to Tg (29~ 30). 
The  immunoglobulin  receptor  on spleen  cells that binds [125I]syngeneic Tg 
was composed of/z-chains and light chains,  since antisera specific for mouse 
/z-chain and for mouse ~, X, and Fd (IgG)  determinants significantly blocked 
the binding of [~SI]syngeneic Tg. The binding site  did not appear  to be in- 
fluenced by anti-IgG-specific  antisera.  It has been reported that both anfi-/~ 658  ROLES  OF  T  AND  B  CELLS  IN  MIIRINE  THYROIDITIS 
and  -3,  (20)  or  only anti-#  (31-33)  heavy-chain serum  significantly inhibit 
the binding of iodinated antigens in normal  spleen cell populations.  Perhaps, 
in  the  immunocompetent B-cell pool,  the  receptors on  cells specific for self- 
antigens are class restricted to #-chains only. 
SUMMARY 
The data presented in this paper support the hypothesis that unresponsive- 
ness to autologous thyroglobulin (Tg)  exists in the T  cells and responsiveness 
exists  in  the  B  cells.  Such  a  conclusion is  based  on  the  results  of  antigen- 
binding studies where few, if any, thymocytes recognized syngeneic Tg. Com- 
parable numbers of antigen-binding lymphocytes for syngeneic Tg were found 
in  the  spleens of normal  intact mice  and of nude mice.  The latter fact sug- 
gested  that  B  cells  exist  which  recognize  self-constituents.  From  antigen- 
suicide experiments, a  clearer picture of the susceptibility of B  cells to iodi- 
nated  self-antigen and of the obligatory role of antibody in  the induction of 
lesions  was  developed.  Only  bone  marrow  cells  (B  cells)  were  affected  by 
[nq]syngeneic Tg, in which case the incidence of lesions was diminished. From 
adoptive transfer experiments, the results demonstrate that unresponsiveness 
may be  terminated by immunization with  a  mixture of heterologous (cross- 
reacting) Tg's. In this situation T  cells are required since a B-cell reconstituted 
host  failed  to  make  antibody  (plaque-forming cells)  and  to  develop lesions. 
T  cells in this form of an unresponsive state may recognize determinants on 
the heterologous Tg unrelated to autologous Tg and as such stimulate the nor- 
mal complement of B cells to produce antibody that both reacts with autologous 
and heterologous Tg. 
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